- Home
- ARQQ vs AMRN Comparison
ARQQ vs AMRN Comparison
Compare ARQQ & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQQ | AMRN |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 339.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | ARQQ | AMRN |
|---|---|---|
| Price | $23.63 | $15.55 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $60.00 | $12.00 |
| AVG Volume (30 Days) | ★ 311.8K | 107.1K |
| Earning Date | 12-09-2025 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $530,000.00 | ★ $226,733,000.00 |
| Revenue This Year | $1,054.72 | N/A |
| Revenue Next Year | $30.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.00 | $7.08 |
| 52 Week High | $62.00 | $20.90 |
Technical Indicators
Market Signals| Indicator | ARQQ | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 52.55 |
| Support Level | $23.22 | $14.50 |
| Resistance Level | $28.15 | $17.31 |
| Average True Range (ATR) | 1.74 | 0.93 |
| MACD | -0.16 | 0.12 |
| Stochastic Oscillator | 14.34 | 46.80 |
Price Performance
Historical ComparisonAbout ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.